Synergistic Protection of Retinal Ganglion Cells (RGCs) by SARM1 Inactivation with CNTF in a Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2024 Feb 9

PMID 38334594

Authors

Yan Guo

Zara Mehrabian

Jeffrey Milbrandt

Aaron DiAntonio

Steven L Bernstein

Affiliations

Soon will be listed here.

Abstract

We evaluated whether inhibiting sterile alpha and (Toll/interleukin receptor (TIR)) motif-containing 1 (SARM1) activity protects retinal ganglion cells (RGCs) following ischemic axonopathy (rodent nonarteritic anterior ischemic optic neuropathy: rNAION) by itself and combined with ciliary neurotrophic factor (CNTF). Genetically modified SARM1(-) rats were rNAION-induced in one eye and compared against equivalently induced wild-type animals of the same background. Optic nerve (ON) diameters were quantified using optical coherence tomography (SD-OCT). RGCs were quantified 30 d post-induction using retinal stereology for Brn3a(+) nuclei. ON sections were analyzed by TEM and immunohistochemistry. SARM1(-)(-) and WT animals were then bilaterally sequentially rNAION-induced. One eye received intravitreal vehicle injection following induction; the contralateral side received CNTF and was analyzed 30 d post-induction. Inhibiting SARM1 activity suppressed axonal collapse following ischemic axonopathy. SARM1(-) animals significantly reduced RGC loss, compared with WT animals (49.4 ± 6.8% RGC loss in SARM1(-) vs. 63.6 ± 3.2% sem RGC loss in WT; Mann-Whitney one-tailed U-test, ( = 0.049)). IVT-CNTF treatment vs. IVT-vehicle in SARM1(-) animals further reduced RGC loss by 24% at 30 d post-induction, but CNTF did not, by itself, improve long-term RGC survival in WT animals compared with vehicle (Mann-Whitney one-tailed -test; = 0.033). While inhibiting SARM1 activity is itself neuroprotective, combining SARM1 inhibition and CNTF treatment generated a long-term, synergistic neuroprotective effect in ischemic neuropathy. Combinatorial treatments for NAION utilizing independent neuroprotective mechanisms may thus provide a greater effect than individual treatment modalities.

References

Huang T, Huang S, Chang C, Lin K, Chang S, Tsai R . Protective effects of systemic treatment with methylprednisolone in a rodent model of non-arteritic anterior ischemic optic neuropathy (rAION). Exp Eye Res. 2014; 131:69-76. DOI: 10.1016/j.exer.2014.12.014. View

Mathews M, Guo Y, Langenberg P, Bernstein S . Ciliary neurotrophic factor (CNTF)-mediated ganglion cell survival in a rodent model of non-arteritic anterior ischaemic optic neuropathy (NAION). Br J Ophthalmol. 2014; 99(1):133-7. PMC: 4477946. DOI: 10.1136/bjophthalmol-2014-305969. View

Krol J, Roska B . Treatment synergy in axon regeneration. Nat Neurosci. 2016; 19(8):983-4. DOI: 10.1038/nn.4344. View

Jo S, Wang E, Benowitz L . Ciliary neurotrophic factor is an axogenesis factor for retinal ganglion cells. Neuroscience. 1999; 89(2):579-91. DOI: 10.1016/s0306-4522(98)00546-6. View

Miller N, Arnold A . Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy. Eye (Lond). 2014; 29(1):65-79. PMC: 4289822. DOI: 10.1038/eye.2014.144. View

Yi Z, Chen L, Wang X, Chen C, Xing Y . Protective Effects of Intravitreal Injection of the Rho-Kinase Inhibitor Y-27632 in a Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy (rAION). J Ophthalmol. 2020; 2020:1485425. PMC: 7366220. DOI: 10.1155/2020/1485425. View

Sato-Yamada Y, Strickland A, Sasaki Y, Bloom J, DiAntonio A, Milbrandt J . A SARM1-mitochondrial feedback loop drives neuropathogenesis in a Charcot-Marie-Tooth disease type 2A rat model. J Clin Invest. 2022; 132(23). PMC: 9711878. DOI: 10.1172/JCI161566. View

Essuman K, Summers D, Sasaki Y, Mao X, DiAntonio A, Milbrandt J . The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD Cleavage Activity that Promotes Pathological Axonal Degeneration. Neuron. 2017; 93(6):1334-1343.e5. PMC: 6284238. DOI: 10.1016/j.neuron.2017.02.022. View

Chang C, Huang T, Huang S, Tsai R . Neuroprotective effects of recombinant human granulocyte colony-stimulating factor (G-CSF) in a rat model of anterior ischemic optic neuropathy (rAION). Exp Eye Res. 2013; 118:109-16. DOI: 10.1016/j.exer.2013.11.012. View

10.

Behbehani R, Mathews M, Sergott R, Savino P . Nonarteritic anterior ischemic optic neuropathy in patients with sleep apnea while being treated with continuous positive airway pressure. Am J Ophthalmol. 2005; 139(3):518-21. DOI: 10.1016/j.ajo.2004.11.004. View

11.

Chan C, Cheng A, Leung C, Cheung C, Yung A, Gong B . Quantitative assessment of optic nerve head morphology and retinal nerve fibre layer in non-arteritic anterior ischaemic optic neuropathy with optical coherence tomography and confocal scanning laser ophthalmoloscopy. Br J Ophthalmol. 2009; 93(6):731-5. DOI: 10.1136/bjo.2008.143297. View

12.

Tesser R, Niendorf E, Levin L . The morphology of an infarct in nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2003; 110(10):2031-5. DOI: 10.1016/S0161-6420(03)00804-2. View

13.

Lantos K, Domotor Z, Farkas N, Kiss S, Szakacs Z, Garami A . Efficacy of Treatments in Nonarteritic Ischemic Optic Neuropathy: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2022; 19(5). PMC: 8910678. DOI: 10.3390/ijerph19052718. View

14.

Howell G, Soto I, Libby R, John S . Intrinsic axonal degeneration pathways are critical for glaucomatous damage. Exp Neurol. 2012; 246:54-61. PMC: 3831512. DOI: 10.1016/j.expneurol.2012.01.014. View

15.

Cho K, Chan P, So K, Yip H, Chung S . Ciliary neurotrophic factor promotes the regrowth capacity but not the survival of intraorbitally axotomized retinal ganglion cells in adult hamsters. Neuroscience. 1999; 94(2):623-8. DOI: 10.1016/s0306-4522(99)00320-6. View

16.

Nguyen Ngo Le M, Wen Y, Ho Y, Kapupara K, Tsai R . Therapeutic Effects of Puerarin Against Anterior Ischemic Optic Neuropathy Through Antiapoptotic and Anti-Inflammatory Actions. Invest Ophthalmol Vis Sci. 2019; 60(10):3481-3491. DOI: 10.1167/iovs.19-27129. View

17.

. Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol. 1996; 114(11):1366-74. DOI: 10.1001/archopht.1996.01100140566007. View

18.

Monavarfeshani A, Yan W, Pappas C, Odenigbo K, He Z, V Segre A . Transcriptomic analysis of the ocular posterior segment completes a cell atlas of the human eye. Proc Natl Acad Sci U S A. 2023; 120(34):e2306153120. PMC: 10450437. DOI: 10.1073/pnas.2306153120. View

19.

Fantone S, Tossetta G, Montironi R, Senzacqua M, Marzioni D, Mazzucchelli R . Ciliary neurotrophic factor (CNTF) and its receptor (CNTFRα) signal through MAPK/ERK pathway in human prostate tissues: a morphological and biomolecular study. Eur J Histochem. 2020; 64(4). PMC: 7586252. DOI: 10.4081/ejh.2020.3147. View

20.

Fernandes K, Mitchell K, Patel A, Marola O, Shrager P, Zack D . Role of SARM1 and DR6 in retinal ganglion cell axonal and somal degeneration following axonal injury. Exp Eye Res. 2018; 171:54-61. PMC: 5964014. DOI: 10.1016/j.exer.2018.03.007. View